Tags

Type your tag names separated by a space and hit enter

Evaluation of zinc sulfate mucoadhesive formulation on recurrent aphthous stomatitis: a randomized double-blind, placebo-controlled clinical trial.
BMC Oral Health. 2020 Jul 28; 20(1):212.BO

Abstract

BACKGROUND

Recurrent aphthous stomatitis (RAS) is a common lesion that affects the oral mucosa. There are several methods to treat RAS, including systemic and topical formulations. This study was conducted to evaluate the anti-inflammatory effect of topical zinc sulfate and its efficacy in the treatment of RAS.

METHODS

A double-blind randomized clinical trial was conducted on 46 patients with RAS. They were randomly assigned into two groups to receive a zinc sulfate mucoadhesive tablet or placebo for 7 days. The pain severity was measured at baseline and daily while the diameter of the lesion was measured at baseline and on days 3, 5, and 7. The obtained data were analyzed in SPSS V.16.

RESULTS

There was no significant difference in the mean diameter of lesions and pain at baseline between the two groups (P = 0.643 and P = 0.842, respectively). However, on the third, fifth, and seventh days of the study, the diameter of the lesion significantly reduced in the intervention group (P = 0.001) and the pain intensity became significantly different between groups from the fourth day of the study (P = 0.001).

CONCLUSION

Zinc sulfate mucoadhesive tablet was effective in recovery and reducing the pain and diameter of the aphthous lesion and could be considered for the treatment of RAS.

TRIAL REGISTRATION

Evaluation of the effectiveness of zinc sulfate mucoadhesive tablet in the improvement of recurrent aphthous stomatitis (RAS), IRCT20151109024975N9. Registered August 1, 2018, https://en.irct.ir/trial/32423 . This project was registered by the Iranian Registry of Clinical Trials (http://www.irct.ir). The IRCT ID was IRCT20151109024975N9.

Authors+Show Affiliations

Department of Oral and Maxillofacial Diseases, Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran.Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.Department of Oral and Maxillofacial Diseases, Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran.Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.Department of Clinical Pharmacy, Faculty of Pharmacy, Cardiovascular Research Center, Mazandaran University of Medical Sciences, Sari, Iran. dr.gohar.eslami@gmail.com.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32723352

Citation

Ghorbani, Anahita, et al. "Evaluation of Zinc Sulfate Mucoadhesive Formulation On Recurrent Aphthous Stomatitis: a Randomized Double-blind, Placebo-controlled Clinical Trial." BMC Oral Health, vol. 20, no. 1, 2020, p. 212.
Ghorbani A, Akbari J, Boorboor M, et al. Evaluation of zinc sulfate mucoadhesive formulation on recurrent aphthous stomatitis: a randomized double-blind, placebo-controlled clinical trial. BMC Oral Health. 2020;20(1):212.
Ghorbani, A., Akbari, J., Boorboor, M., Nekoukar, Z., & Eslami, G. (2020). Evaluation of zinc sulfate mucoadhesive formulation on recurrent aphthous stomatitis: a randomized double-blind, placebo-controlled clinical trial. BMC Oral Health, 20(1), 212. https://doi.org/10.1186/s12903-020-01194-4
Ghorbani A, et al. Evaluation of Zinc Sulfate Mucoadhesive Formulation On Recurrent Aphthous Stomatitis: a Randomized Double-blind, Placebo-controlled Clinical Trial. BMC Oral Health. 2020 Jul 28;20(1):212. PubMed PMID: 32723352.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Evaluation of zinc sulfate mucoadhesive formulation on recurrent aphthous stomatitis: a randomized double-blind, placebo-controlled clinical trial. AU - Ghorbani,Anahita, AU - Akbari,Jafar, AU - Boorboor,Maryam, AU - Nekoukar,Zahra, AU - Eslami,Gohar, Y1 - 2020/07/28/ PY - 2020/03/18/received PY - 2020/07/13/accepted PY - 2020/7/30/entrez PY - 2020/7/30/pubmed PY - 2020/7/30/medline KW - Mucoadhesive formulation KW - Recurrent aphthous stomatitis KW - Zinc SP - 212 EP - 212 JF - BMC oral health JO - BMC Oral Health VL - 20 IS - 1 N2 - BACKGROUND: Recurrent aphthous stomatitis (RAS) is a common lesion that affects the oral mucosa. There are several methods to treat RAS, including systemic and topical formulations. This study was conducted to evaluate the anti-inflammatory effect of topical zinc sulfate and its efficacy in the treatment of RAS. METHODS: A double-blind randomized clinical trial was conducted on 46 patients with RAS. They were randomly assigned into two groups to receive a zinc sulfate mucoadhesive tablet or placebo for 7 days. The pain severity was measured at baseline and daily while the diameter of the lesion was measured at baseline and on days 3, 5, and 7. The obtained data were analyzed in SPSS V.16. RESULTS: There was no significant difference in the mean diameter of lesions and pain at baseline between the two groups (P = 0.643 and P = 0.842, respectively). However, on the third, fifth, and seventh days of the study, the diameter of the lesion significantly reduced in the intervention group (P = 0.001) and the pain intensity became significantly different between groups from the fourth day of the study (P = 0.001). CONCLUSION: Zinc sulfate mucoadhesive tablet was effective in recovery and reducing the pain and diameter of the aphthous lesion and could be considered for the treatment of RAS. TRIAL REGISTRATION: Evaluation of the effectiveness of zinc sulfate mucoadhesive tablet in the improvement of recurrent aphthous stomatitis (RAS), IRCT20151109024975N9. Registered August 1, 2018, https://en.irct.ir/trial/32423 . This project was registered by the Iranian Registry of Clinical Trials (http://www.irct.ir). The IRCT ID was IRCT20151109024975N9. SN - 1472-6831 UR - https://www.unboundmedicine.com/medline/citation/32723352/Evaluation_of_zinc_sulfate_mucoadhesive_formulation_on_recurrent_aphthous_stomatitis:_a_randomized_double_blind_placebo_controlled_clinical_trial_ L2 - https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-020-01194-4 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.